Search results
PROMOTED
Start date:
Mar 26, 2024
Added:
3 years ago
Positron emission tomography (PET) has contributed significantly to advancing our understanding of heart physiology and pathophysiology for more than 25 years. Despite its clear success in research applications, the restricted availability of this technology, its increased cost and limited data supporting its use and reimbursement have all contributed to the relatively limited clinical acceptance…
View more
Added:
3 years ago
Positron emission tomography (PET) has contributed significantly to advancing our understanding of heart physiology and pathophysiology for more than 25 years. Despite its clear success in research applications, the restricted availability of this technology, its increased cost and limited data supporting its use and reimbursement have all contributed to the relatively limited clinical acceptance…
View more
Added:
3 years ago
Clinical applications of cardiac positron emission tomography (PET) have made dramatic advances over the past three years, particularly in myocardial perfusion imaging. These advances include cardiac-specific PET technology, specialized software, and profound biological insights into myocardial perfusion far beyond the traditional binary interpretation of perfusion images as normal or abnormal…
View more
Added:
3 years ago
Clinical applications of cardiac positron emission tomography (PET) have made dramatic advances over the past three years, particularly in myocardial perfusion imaging. These advances include cardiac-specific PET technology, specialized software, and profound biological insights into myocardial perfusion far beyond the traditional binary interpretation of perfusion images as normal or abnormal…
View more
Added:
3 years ago
Source:
Lantheus Medical Imaging
N. BILLERICA, Mass. (October 29, 2013) – Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced preliminary results from the first of two planned Phase 3 trials to assess the diagnostic efficacy of flurpiridaz F 18, an imaging agent used in Positron Emission Tomography (PET) myocardial perfusion imaging …
View more
Added:
3 years ago
With ageing of the general population and broadening indications, the number of pacemaker recipients is steadily increasing. The incidence of cardiac implantable electronic device (CIED) infection, a dreaded major complication, is also rising.1 The diagnosis is based on the presence of an abscessed pocket, cutaneous breakthrough of the pulse generator or vegetations attached to the pacemaker lead…
View more
Added:
3 years ago
The heart requires a high rate of oxygen uptake to maintain mechanical function in order to provide sufficient energy to balance the requirement of the mechanical function. Oxygen consumption increases in almost direct ratio to the increased workload; when the oxygen supply is inadequate for the demand, reversible or irreversible metabolic changes may occur. Such an imbalance is most often…
View more
Added:
3 years ago
Myocardial blood flow (MBF) must respond to changes in metabolic conditions and oxygen requests to meet the needs of myocytes, and autoregulation plays a mayor role in the control of coronary circulation.1–3 It has been demonstrated that, as a coronary artery is progressively narrowed, resting flow does not change at first, but maximal flow (achieved by injecting a vasodilator) decreases…
View more
Added:
3 years ago
More than 20 million people worldwide are estimated to have been diagnosed with congestive heart failure (CHF).1 In the US, more than 5.8 million cases have been reported, with approximately 670,000 new cases each year.2 Heart failure is a diagnosis associated with high morbidity and mortality. CHF can be categorized as either systolic (reduced left ventricular ejection fraction) or diastolic …
View more
